Artivion (AORT) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Artivion Revenue Highlights

Latest Revenue (Y)

$388.54M

Latest Revenue (Q)

$95.78M

Main Segment (Y)

Products

Main Geography (Y)

North America Segment

Artivion Revenue by Period

Artivion Revenue by Year

Date	Revenue	Change
2024-12-31	$388.54M	9.75%
2023-12-31	$354.00M	12.82%
2022-12-31	$313.79M	5.00%
2021-12-31	$298.84M	18.01%
2020-12-31	$253.23M	-8.32%
2019-12-31	$276.22M	5.09%
2018-12-31	$262.84M	38.55%
2017-12-31	$189.70M	5.17%
2016-12-31	$180.38M	23.63%
2015-12-31	$145.90M	0.87%
2014-12-31	$144.64M	2.75%
2013-12-31	$140.76M	6.87%
2012-12-31	$131.72M	10.11%
2011-12-31	$119.63M	2.56%
2010-12-31	$116.64M	4.44%
2009-12-31	$111.69M	6.31%
2008-12-31	$105.06M	10.87%
2007-12-31	$94.76M	16.54%
2006-12-31	$81.31M	17.36%
2005-12-31	$69.28M	11.06%
2004-12-31	$62.38M	4.79%
2003-12-31	$59.53M	-23.48%
2002-12-31	$77.80M	-11.26%
2001-12-31	$87.67M	13.72%
2000-12-31	$77.10M	15.55%
1999-12-31	$66.72M	9.92%
1998-12-31	$60.70M	19.25%
1997-12-31	$50.90M	37.57%
1996-12-31	$37.00M	27.59%
1995-12-31	$29.00M	22.88%
1994-12-31	$23.60M	11.32%
1993-12-31	$21.20M	-

Artivion generated $388.54M in revenue during NA 2024, up 9.75% compared to the previous quarter, and up 140.66% compared to the same period a year ago.

Artivion Revenue by Quarter

Date	Revenue	Change
2024-09-30	$95.78M	-2.29%
2024-06-30	$98.02M	0.60%
2024-03-31	$97.43M	4.02%
2023-12-31	$93.67M	6.62%
2023-09-30	$87.85M	-1.57%
2023-06-30	$89.25M	7.24%
2023-03-31	$83.23M	4.83%
2022-12-31	$79.40M	3.33%
2022-09-30	$76.84M	-4.36%
2022-06-30	$80.34M	4.05%
2022-03-31	$77.21M	-2.75%
2021-12-31	$79.39M	9.95%
2021-09-30	$72.21M	-5.18%
2021-06-30	$76.15M	7.12%
2021-03-31	$71.09M	4.70%
2020-12-31	$67.90M	4.25%
2020-09-30	$65.13M	21.13%
2020-06-30	$53.77M	-19.05%
2020-03-31	$66.43M	-4.69%
2019-12-31	$69.70M	2.68%
2019-09-30	$67.88M	-4.58%
2019-06-30	$71.14M	5.38%
2019-03-31	$67.50M	-0.43%
2018-12-31	$67.80M	4.96%
2018-09-30	$64.60M	-5.69%
2018-06-30	$68.50M	10.57%
2018-03-31	$61.95M	17.27%
2017-12-31	$52.83M	20.06%
2017-09-30	$44.00M	-7.99%
2017-06-30	$47.82M	6.12%
2017-03-31	$45.06M	0.07%
2016-12-31	$45.03M	-0.49%
2016-09-30	$45.25M	-3.89%
2016-06-30	$47.08M	9.45%
2016-03-31	$43.02M	7.98%
2015-12-31	$39.84M	8.54%
2015-09-30	$36.70M	3.31%
2015-06-30	$35.53M	5.01%
2015-03-31	$33.83M	-8.94%
2014-12-31	$37.15M	0.22%
2014-09-30	$37.07M	6.86%
2014-06-30	$34.69M	-2.91%
2014-03-31	$35.73M	0.77%
2013-12-31	$35.46M	-2.19%
2013-09-30	$36.25M	8.14%
2013-06-30	$33.52M	-5.67%
2013-03-31	$35.54M	8.34%
2012-12-31	$32.80M	-1.88%
2012-09-30	$33.43M	0.73%
2012-06-30	$33.19M	2.75%
2012-03-31	$32.30M	6.26%
2011-12-31	$30.40M	2.51%
2011-09-30	$29.65M	0.94%
2011-06-30	$29.38M	-2.71%
2011-03-31	$30.20M	3.33%
2010-12-31	$29.22M	2.74%
2010-09-30	$28.44M	-2.80%
2010-06-30	$29.26M	-1.53%
2010-03-31	$29.72M	3.85%
2009-12-31	$28.61M	1.40%
2009-09-30	$28.22M	0.20%
2009-06-30	$28.16M	5.53%
2009-03-31	$26.69M	4.53%
2008-12-31	$25.53M	-4.75%
2008-09-30	$26.80M	-1.29%
2008-06-30	$27.16M	6.21%
2008-03-31	$25.57M	1.99%
2007-12-31	$25.07M	-

Artivion generated $95.78M in revenue during Q3 2024, up -2.29% compared to the previous quarter, and up 107.31% compared to the same period a year ago.

Artivion Revenue Breakdown

Artivion Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Products	$290.23M	$261.19M	$230.35M	$221.60M	$179.30M
On X	$83.98M	$74.53M	$63.90M	$57.36M	$48.05M
Other Products	$9.27M	$11.17M	$8.32M	$8.13M	-
Surgical Sealants	$73.90M	$68.02M	$65.38M	$70.71M	-
Aortic Stent Grafts	$123.08M	$107.47M	-	-	-
Preservation Services	-	-	$83.44M	$77.24M	$73.93M
Aortic Stents And Stent Grafts	-	-	$92.75M	$85.39M	$61.66M
Per Clot	-	-	-	-	$2.88M
Photofix	-	-	-	-	$4.17M
Vascular Tissue	-	-	-	-	$35.85M
Bioglue	-	-	-	-	$62.07M
Cardiac Tissue	-	-	-	-	$37.89M
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	$464.00K
Neopatch	-	-	-	-	$183.00K

Artivion's latest annual revenue breakdown by segment (product or service), as of Dec 24: Products (50.00%), Aortic Stent Grafts (21.20%), On X (14.47%), Surgical Sealants (12.73%), and Other Products (1.60%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Aortic Stent Grafts	$62.34M	$28.64M	$32.10M	$27.44M	$25.52M	$28.36M	$26.15M	$19.67M	$23.83M	$25.51M	-	-	-	-	-	-	-	-	-	-
On X	$42.82M	$21.48M	$19.68M	$20.18M	$18.74M	$17.95M	$17.66M	$16.46M	$16.25M	$14.37M	$14.02M	$14.73M	$13.10M	$13.67M	$12.07M	$10.12M	$12.20M	$13.35M	$12.61M	-
Surgical Sealants	$38.48M	$18.44M	$16.98M	$18.51M	$16.23M	$16.57M	$16.70M	$17.37M	$15.97M	$15.68M	$16.54M	$17.86M	$17.83M	-	-	-	-	-	-	-
Other Products	$4.23M	$2.69M	$2.35M	$3.01M	$3.25M	$3.13M	$1.78M	$1.74M	$2.88M	$1.98M	$1.65M	$2.42M	$2.22M	-	-	-	-	-	-	-
Products	$147.87M	$71.24M	$71.11M	$69.14M	$63.75M	$66.00M	$62.29M	$55.25M	$58.94M	$57.54M	$53.11M	$56.08M	$53.34M	$50.50M	-	-	-	-	-	-
Cardiogenesis	-	-	-	-	-	-	-	$389.00K	-	-	-	-	-	-	-	-	-	-	-	-
International Hospitals	-	-	-	-	-	-	-	$25.30M	-	-	-	-	-	-	-	-	-	-	-	-
International Distributor	-	-	-	-	-	-	-	$12.92M	-	-	-	-	-	-	-	-	-	-	-	-
Domestic Hospitals	-	-	-	-	-	-	-	$40.79M	-	-	-	-	-	-	-	-	-	-	-	-
Aortic Stents And Stent Grafts	-	-	-	-	-	-	-	-	-	-	-	$20.90M	$21.06M	$20.20M	-	-	-	-	-	-
Bioglue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.08M	$15.81M	$12.44M	$16.74M	-	-
Cardiac Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.13M	$10.68M	$8.06M	$10.03M	$10.14M	$11.30M
Vascular Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.20M	$9.29M	$9.98M	$9.36M	$9.09M	-
Photofix	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.11M	$1.13M	$880.00K	$1.04M	$1.00M	$1.09M
Preservation Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.39M	-	-	-	-	-
Per Clot	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$801.00K	$724.00K	$497.00K	$860.00K	$981.00K	$980.00K
Neopatch	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.00K	$58.00K	-	-	-	-
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$106.00K	$83.00K	$164.00K	$111.00K	$1.05M	$1.35M
Jotec Ag	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.29M	$13.17M	$15.27M	$16.04M	$15.77M
Nexus	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$200.00K	-	-
Bio Glue And Bio Foam	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.68M

Artivion's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Products (50.00%), Aortic Stent Grafts (21.08%), On X (14.48%), Surgical Sealants (13.01%), and Other Products (1.43%).

Artivion Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Asia Pacific Segment	$37.20M	-	-	-	-
Latin America Segment	$21.88M	-	-	-	-
North America Segment	$197.94M	-	-	-	-
Europe, the Middle East, and Africa Segments	$131.52M	-	-	-	-
Non-US	-	$174.52M	$152.68M	-	-
UNITED STATES	-	$179.49M	$161.11M	-	-
U	-	-	-	$151.15M	$138.27M
Non Us	-	-	-	$147.69M	$114.95M

Artivion's latest annual revenue breakdown by geography, as of Dec 24: North America Segment (50.94%), Europe, the Middle East, and Africa Segments (33.85%), Asia Pacific Segment (9.57%), and Latin America Segment (5.63%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24
Europe, the Middle East, and Africa Segments	$67.51M	$30.42M	$33.59M
Asia Pacific Segment	$19.23M	$10.37M	$7.61M
North America Segment	$97.92M	$49.09M	$50.93M
Latin America Segment	$10.67M	$5.90M	$5.31M

Artivion's latest quarterly revenue breakdown by geography, as of Dec 24: North America Segment (50.13%), Europe, the Middle East, and Africa Segments (34.56%), Asia Pacific Segment (9.84%), and Latin America Segment (5.46%).

Artivion Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	$1.72B	$746.27M
CNMD	CONMED	$1.31B	$316.70M
AVNS	Avanos Medical	$687.80M	$170.40M
AORT	Artivion	$388.54M	$95.78M
TMCI	Treace Medical Concepts	$209.36M	$45.09M
KIDS	OrthoPediatrics	$204.73M	$52.80M
AXGN	AxoGen	$187.34M	$48.64M
SIBN	SI-BONE	$167.18M	$40.34M
ANIK	Anika Therapeutics	$166.66M	$38.75M
ESTA	Establishment Labs	$166.03M	$40.23M
SRDX	Surmodics	$126.08M	$29.92M
LUNG	Pulmonx	$83.79M	$20.39M
NPCE	NeuroPace	$79.91M	$21.06M
SGHT	Sight Sciences	$79.87M	$20.16M
CVRX	CVRx	$51.29M	$13.37M
OFIX	Orthofix Medical	-	$198.62M

AORT Revenue FAQ

What is Artivion’s yearly revenue?

Artivion's yearly revenue for 2024 was $388.54M, representing an increase of 9.75% compared to 2023. The company's yearly revenue for 2023 was $354M, representing an increase of 12.82% compared to 2022. AORT's yearly revenue for 2022 was $313.79M, representing an increase of 5.00% compared to 2021.

What is Artivion’s quarterly revenue?

Artivion's quarterly revenue for Q3 2024 was $95.78M, a -2.29% decrease from the previous quarter (Q2 2024), and a 9.02% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $98.02M, a 0.60% increase from the previous quarter (Q1 2024), and a 9.82% increase year-over-year (Q2 2023). AORT's quarterly revenue for Q1 2024 was $97.43M, a 4.02% increase from the previous quarter (Q4 2023), and a 17.06% increase year-over-year (Q1 2023).

What is Artivion’s revenue growth rate?

Artivion's revenue growth rate for the last 3 years (2022-2024) was 23.82%, and for the last 5 years (2020-2024) was 53.43%.

What are Artivion’s revenue streams?

Artivion's revenue streams in c 24 are Products, On X, Other Products, Surgical Sealants, and Aortic Stent Grafts. Products generated $290.23M in revenue, accounting 50.00% of the company's total revenue, up 11.12% year-over-year. On X generated $83.98M in revenue, accounting 14.47% of the company's total revenue, up 12.69% year-over-year. Other Products generated $9.27M in revenue, accounting 1.60% of the company's total revenue, down -17.03% year-over-year. Surgical Sealants generated $73.9M in revenue, accounting 12.73% of the company's total revenue, up 8.65% year-over-year. Aortic Stent Grafts generated $123.08M in revenue, accounting 21.20% of the company's total revenue, up 14.53% year-over-year.

What is Artivion’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Artivion was Products. This segment made a revenue of $290.23M, representing 50.00% of the company's total revenue.